We Can Business Summary

We Can Medicines Co., Ltd. (6929.TWO) is a leading Taiwan-based drugstore chain operator that generates revenue through the wholesale, import, and retail distribution of a comprehensive healthcare portfolio. The company’s primary business segments encompass pharmaceuticals (Western and traditional Chinese), health foods, maternal and infant products, medical equipment, and beauty cosmetics. Operating under the VITALPLUS and Sapporo brands, We Can utilizes a hybrid model of physical retail outlets and e-commerce platforms, supplemented by ancillary income from pharmacy management fees and royalty arrangements. In the competitive Taiwanese landscape, the company maintains a specialized market position relative to larger-scale peers such as Great Tree Pharmacy (6469.TWO), MedFirst Healthcare Services (4175.TWO), and Norbel Baby (6844.TWO), focusing on high-service cosmeceutical and family wellness niches. The company is led by CEO Te-Lan Wen (De-Lan Wen), who oversees a workforce of approximately 1,000 employees from its corporate headquarters in Taichung. We Can Medicines operates as a strategic subsidiary of Yousheng Medical Technology Co., Ltd., leveraging the parent group’s extensive medical distribution pedigree and supply chain infrastructure. The company’s institutional investor base and board are bolstered by notable industry stakeholders, including Rossmax International Ltd., Standard Chemical & Pharmaceutical Co., Ltd., and the major e-commerce platform momo.com Inc. This cross-sector backing from pharmaceutical manufacturers and retail giants provides the firm with significant capital and logistical advantages in the domestic pharmacy and healthcare retail market.